US Stock MarketDetailed Quotes

AVBP ArriVent BioPharma

Watchlist

27.460
+0.870+3.27%

Trading Nov 22 15:50 ET

925.32MMarket Cap-11417P/E (TTM)

ArriVent BioPharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

ArriVent BioPharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 0.000	--
--	2024/Q4	-- / 0.000	--
--	2024/Q3	0.000 / 0.000	--
--	2024/Q2	0.000 / 0.000	--
--	2024/Q1	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 0.000--

--2024/Q4-- / 0.000--

--2024/Q30.000 / 0.000--

--2024/Q20.000 / 0.000--

--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Open Account

ArriVent BioPharma Earnings Reports

ArriVent BioPharma | 10-Q: Q3 2024 Earnings Report

Nov 14 08:06 ET

ArriVent BioPharma | 8-K: ArriVent BioPharma Reports Third Quarter 2024 Financial Results

Nov 14 08:06 ET

ArriVent BioPharma | 10-Q: Q2 2024 Earnings Report

Aug 14 16:22 ET

ArriVent BioPharma | 8-K: ArriVent BioPharma Reports Second Quarter 2024 Financial Results

Aug 14 16:12 ET

Analyst Rating

Updated: Nov 15, 2024

Strong Buy

Buy
100.00%
Hold
0.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall